FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's Eletriptan Hydrobromide as an original generic application (ANDA) for the acute treatment of migraine with or without aura in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Eletriptan Hydrobromide (eletriptan hydrobromide)

Snippet

ORIG AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)